WAY-621089 is an active molecule for the study of amyloid diseases and synucleinopathies[1].
References
[1] Segura-Cabrera A, et al. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3152-7. DOI:10.1016/j.bmcl.2008.05.003